Aerpio Pharmaceuticals Inc. (ARPO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aerpio Pharmaceuticals In...

    NASDAQ: ARPO · Real-Time Price · USD
    2.20
    -0.02 (-0.90%)
    At close: Aug 27, 2021, 6:00 AM

    Aerpio Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 25.98M 5.51M 4.47M
    Cost of Revenue
    		 n/a 35.02M 20.02M
    Gross Profit
    		 n/a -29.51M -15.54M
    Operating Income
    		 -67.46M -36.95M -23.82M
    Interest Income
    		 3.92M 29K 59K
    Pretax Income
    		 -63.69M -36.92M -23.16M
    Net Income
    		 -63.69M -36.92M -23.16M
    Selling & General & Admin
    		 36.75M 7.44M 8.28M
    Research & Development
    		 51.03M 35.02M 20.02M
    Other Expenses
    		 5.66M n/a n/a
    Operating Expenses
    		 93.44M 7.44M 7.55M
    Interest Expense
    		 -154K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 n/a 42.45M 27.57M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 27.03M 34.29M 24.1M
    Shares Outstanding (Diluted)
    		 27.03M 34.29M 24.1M
    EPS (Basic)
    		 -2.36 -1.08 -0.96
    EPS (Diluted)
    		 -2.36 -1.08 -0.96
    EBITDA
    		 -67.46M -36.05M -22.65M
    EBIT
    		 n/a -36.95M -23.82M
    Depreciation & Amortization
    		 n/a 892K 1.17M

    Add to Watchlist